ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT

July 1, 1988

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.

November 29, 1996

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003